Kane Biotech Inc Ord (KNBIF) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kane Biotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.233 -- 00:00:02.095 Good afternoon, and thank you for standing by. 00:00:02.095 -- 00:00:07.259 Welcome to Kean Biotech's fourth quarter and full year 2023 earnings conference 00:00:07.259 -- 00:00:12.484 call. During today's presentation, all parties will be in a listen-only mode. 00:00:12.484 -- 00:00:16.408 Following the presentation, the conference call will be open to questions. 00:00:16.408 -- 00:00:21.252 If you have a question, please press star 1-1 on your touchtone phone. 00:00:21.252 -- 00:00:24.795 If you'd like to withdraw your question, please press star 1-1 again. 00:00:24.795 -- 00:00:30.198 This conference is being recorded today, March 26, 2024. 00:00:31.672 -- 00:00:35.976 I would like to turn the conference call over to Ray Dupuy, Kean Biotech's Chief Financial 00:00:35.976 -- 00:00:39.157 Officer. Please go ahead. 00:00:39.320 -- 00:00:44.425 Thank you, Operator. Good afternoon and welcome, everyone, to Kean Biotech's fourth quarter 00:00:44.425 -- 00:00:48.088 and full year 2023 earnings conference call. 00:00:48.088 -- 00:00:50.611 We are delighted to have you join us today. 00:00:50.611 -- 00:00:54.635 This call will cover Kean's financial and operating results, along with a discussion 00:00:54.635 -- 00:00:59.500 of some of our recent highlights and goals for 2024 and beyond. 00:00:59.500 -- 00:01:03.759 Following our prepared remarks, we will open the conference call to a question and answer 00:01:03.759 -- 00:01:08.824 session. Our call today will be led by King's chief executive officer, 00:01:08.824 -- 00:01:10.706 Mark Edwards. 00:01:10.706 -- 00:01:13.389 Before we begin our formal remarks, 00:01:13.389 -- 00:01:17.072 I would like to remind everyone that some of the statements on this conference call contain 00:01:17.07...